Clinical Trials Directory

Trials / Completed

CompletedNCT01842958

Straumann Roxolid Multi-Center Study

A Randomized, Controlled, Multi-center Clinical Study Evaluating the Crestal Bone Level Changes of Straumann BL Ø 3.3 mm NC SLActive RXD Implants Compared to Straumann BL Ø 4.1 mm RC SLActive RXD Implants for Single Tooth Replacement.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Institut Straumann AG · Industry
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant placement. The secondary objectives will assess differences in clinical outcomes between the test and control implants, including implant success and survival, gingival recession, subject satisfaction and additional early bone level measurements.

Detailed description

This is a randomized, controlled, multi-center clinical study. The total study duration for each patient should be 12 ± 1 months. Straumann Bone Level implants will be placed in the pre-molar or anterior region of the mandible or maxilla for single tooth replacement, followed by provisional prosthetic loading after 25 ± 4 days and by final prosthetic loading 6 ± 1 months after implant loading. In total 6 visits per patient are scheduled in this study. Bone level changes, implant success and survival, gingival recession, subject satisfaction and adverse events (AEs) will be assessed. The study devices are CE-(Conformité Européenne, meaning European Conformity) marked products. Straumann Bone Level implants Ø 3.3 mm NC SLActive Roxolid and Straumann Bone Level Ø 4.1 mm RC SLActive implants. Five centers in USA will participate.

Conditions

Interventions

TypeNameDescription
DEVICEStraumann Bone Level Implants, 4.1 mm implant diameterStraumann Bone Level Implants, 4.1 mm implant diameter
DEVICEStraumann Bone Level Implants, 3.3 mm implant diameterStraumann Bone Level Implants, 3.3 mm implant diameter

Timeline

Start date
2013-03-01
Primary completion
2016-01-01
Completion
2016-03-01
First posted
2013-04-30
Last updated
2018-02-15
Results posted
2018-02-15

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01842958. Inclusion in this directory is not an endorsement.